Trump deadline for drug pricing order passes with no action
Source: The Hill
A deadline set by President Trump for moving forward with an executive order to lower drug prices passed at midnight on Tuesday without any action so far from the White House.
Trump held a highly-touted signing ceremony on July 24 for four executive orders aimed at lowering drug prices, a key issue for voters ahead of the election. But on the most consequential of the orders, to lower certain Medicare drug prices by tying prices to those paid in other countries, Trump delayed the order for one month, until Aug. 24, saying he wanted to give the pharmaceutical industry time to make a deal.
That deadline has now come and gone, without the announcement of any deal with drug companies, yet the White House has not moved forward with the order and is not saying if it will.
The White House declined to comment when asked about the path forward for the order on Tuesday.
Read more: https://thehill.com/policy/healthcare/513518-trump-deadline-for-drug-pricing-order-passes-with-no-action
The order in question is called a most-favored nation clause, and is aimed at lowering the prices for a subset of drugs paid for by Medicare to be in line with the lower prices paid in other developed countries.
still_one
(92,302 posts)CrispyQ
(36,487 posts)magicarpet
(14,157 posts)Claustrum
(4,845 posts)Or in reality, his empty words will disappear the day after the election because he never cared about them. He just gives lip service to buy time.
bucolic_frolic
(43,236 posts)No suburbs either.
Evolve Dammit
(16,750 posts)Maxheader
(4,373 posts)The amreicun pharm nazi can't afford their yachts without
marked up meds..
left-of-center2012
(34,195 posts)Showed him signing the executive order
and a HUGE trumpian smile.
dalton99a
(81,543 posts)Eugene
(61,919 posts)Source: Politico
Drugmakers pitched a counteroffer to the White House aimed at stalling Trump's plan to link Medicares spending on some expensive drugs to much lower prices.
By SARAH OWERMOHLE and SUSANNAH LUTHI
08/25/2020 05:54 PM EDT
Drugmakers pitched a counteroffer to the White House aimed at stalling President Donald Trump's plan to link Medicares spending on some expensive drugs to much lower prices they're sold for abroad, according to an internal memo circulated to industry lobbyists Monday.
The proposal would save Medicare considerably less money than the administration's original international pricing index plan. But it could give Trump evidence he's making good on his 2016 campaign pledge to lower prescription drug prices before the election.
The drug industry memo comes days after Trumps publicly announced deadline for the industry to provide an alternative to his so-called most favored nations rule. Pharmaceutical executives have downplayed any interest in negotiating with the president during their recent company earnings calls.
Four industry sources confirmed that industry shared the proposal with the White House. The board of PhRMA, the brand-name drug industry's big Washington lobby, approved the proposal Sunday and it was transmitted to the White House shortly thereafter, said one lobbyist. The plan was for the president to be briefed directly on the counteroffer, but it is not clear that he has yet.
PhRMA and the White House did not respond to requests for comment.
-snip-
Read more: https://www.politico.com/news/2020/08/25/trump-drug-pricing-pharma-401775